Asana BioSciences, LLC
36Patents
35Active
36Granted
53Portfolio score
Filing activity: Feb 18, 2012 → Mar 29, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9382277B2 | Pyrimido-pyridazinone compounds and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US9944637B2 | P2X3 and/or P2X2/3 compounds and methods | Chemistry; Metallurgy | 4 | Active |
| US9908879B2 | P2X3 and/or P2X2/3 compounds and methods | Chemistry; Metallurgy | 4 | Active |
| US9499495B2 | Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways | Physics | 3 | Active |
| US10751332B2 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Chemistry; Metallurgy | 2 | Active |
| US10316039B2 | P2X3 and/or P2X2/3 compounds and methods | Chemistry; Metallurgy | 2 | Active |
| US10174039B2 | P2X3 and/or P2X2/3 compounds and methods | Chemistry; Metallurgy | 2 | Active |
| US10316080B2 | Protein-polymer-drug conjugates | Human Necessities | 2 | Active |
| US10471051B2 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Chemistry; Metallurgy | 2 | Active |
| US10188654B2 | Uses of pyrimido-pyridazinones to treat cancer | Human Necessities | 2 | Active |
| US10611768B2 | P2X3 and/or P2X2/3 compounds and methods | Chemistry; Metallurgy | 1 | Active |
| US11103491B2 | Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US10183944B2 | Pyrimido-pyridazinone compounds and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US8809372B2 | Pyridine derivatives | Chemistry; Metallurgy | 1 | Active |
| US10544145B2 | P2X3 and/or P2X2/3 compounds and methods | Chemistry; Metallurgy | 1 | Active |
| US11339169B2 | P2X3 and/or P2X2/3 compounds and methods | Chemistry; Metallurgy | 1 | Active |
| US9375423B2 | Use of aminoindane compounds in treating overactive bladder and interstitial cystitis | Chemistry; Metallurgy | 1 | Active |
| US10647720B2 | Pyrimido-pyridazinone compounds and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US10590127B2 | P2X3 and/or P2X2/3 compounds and methods | Chemistry; Metallurgy | 1 | Active |
| US9044482B2 | Use of aminoindane compounds in treating overactive bladder and interstitial cystitis | Chemistry; Metallurgy | 1 | Active |
| US9757382B2 | Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways | Physics | 0 | Active |
| US9180115B2 | Cyclohexylamines | Chemistry; Metallurgy | 0 | Active |
| US10912779B2 | Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways | Physics | 0 | Active |
| US8865741B2 | Aminoindane compounds and use thereof in treating pain | Chemistry; Metallurgy | 0 | Active |
| US9266873B2 | Pyridine derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.